In some countries, this medicine may only be approved for veterinary use.
In the US, Naltrexone (naltrexone systemic) is a member of the following drug classes: antidotes, drugs used in alcohol dependence and is used to treat Alcohol Dependence, Fibromyalgia, Opiate Dependence and Trichotillomania.
US matches:
- Naltrexone
- Naltrexone injection
- Naltrexone Intramuscular
- Naltrexone Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N07BB04
CAS registry number (Chemical Abstracts Service)
0016590-41-3
Chemical Formula
C20-H23-N-O4
Molecular Weight
341
Therapeutic Category
Opioid receptor antagonist
Chemical Name
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5α)-
Foreign Names
- Naltrexonum (Latin)
- Naltrexon (German)
- Naltrexone (French)
- Naltrexona (Spanish)
Generic Names
- Naltrexone (OS: DCF, DCIT, USAN, BAN)
- UM 792 (IS)
- Naltrexone Hydrochloride (OS: BANM)
- EN-1639 A (IS: DuPont Merck)
- Naltrexone Hydrochloride (PH: BP 2010, Ph. Eur. 6, USP 32)
- Naltrexoni hydrochloridum (PH: Ph. Eur. 6)
Brand Names
- Naltrekson
Wyeth, Slovenia - Naltrexona Mallinckrodt
Generis, Portugal - Naltrexone aop
AOP, Lithuania - Naltrexone
Alhavi, Georgia - Revia
Apotex, Canada - Vivitrol
Alkermes, United States; Cephalon, United States - Antaxon
Zambon, Georgia; Zambon, Hungary - Antaxone
Pharmazam, Spain; Zambon, Italy; Zambon, Portugal; Zambon, Serbia; Zambon, Russian Federation - Basinal
Basi, Portugal - Celupan
Lacer, Spain - Depade
Mallinckrodt, United States - Dependex
Amomed, Austria - Destoxican
Pentafarma, Portugal - Embeda (Naltrexone and Morphine)
King, United States - Ethylex
AOP Orphan, Bulgaria; Orpha-Devel, Austria - Nalerona
Silesia, Chile; Silesia, Peru - Nalorex
Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Netherlands; Eureco, Netherlands; Molteni, Italy; Schering-Plough, France; Vianex / BIANEΞ, Greece; Vitoria, Portugal - Naltax
Navana, Bangladesh - Naltrax
Navana, Bangladesh - Naltrexin
OrPha, Switzerland; Orpha-Devel, Austria - Naltrexon AOP
Orphan Pharmaceuticals AOP, Denmark - Naltrexon HCl aop
Orphan, Netherlands - Naltrexon HCl Sandoz
Sandoz, Netherlands - Naltrexon Hexal
Hexal, Austria - Naltrexon Vitaflo
Berren, Finland; Vitaflo, Sweden - Naltrexona Destoxican
Pentafarma, Portugal - Naltrexone Hydrochloride
Actavis, United States; Amide, United States; Mallinckrodt, United States; Sandoz, United States; Teva USA, United States - Naltrexone Mylan
Mylan, France - Naltrexone
AOP, Latvia - Naltrexonhydrochloride PCH
Pharmachemie, Netherlands - Narcoral
Sirton Medicare, Italy - Nemexin
Bristol-Myers Squibb, Germany; Torrex, Czech Republic; Torrex Chiesi, Austria - Nodict
Sun, India - Opizone
Genus, United Kingdom - Revez
Soubeiran Chobet, Argentina - Revia Gervasi Farmacia
Gervasi, Spain - Revia
Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Taiwan; Cristália, Brazil; Duramed, United States; Eurim, Austria; Euro, Netherlands; Providens, Croatia (Hrvatska); Torrex, Czech Republic; Torrex, Estonia; Torrex, Latvia; Torrex, Slovenia; Torrex Chiesi, Austria - Trexonil (veterinary use)
Wildlife, United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment